Literature DB >> 22945746

Reliability of the electrical perceptual threshold and Semmes-Weinstein monofilament tests of cutaneous sensibility.

P H Ellaway1, M Catley.   

Abstract

STUDY
DESIGN: Prospective experimental.
OBJECTIVES: To compare the reliability and repeatability of the electrical perceptual threshold (EPT) and Semmes-Weinstein monofilament (SWM) tests for cutaneous sensibility. EPT and SWM tests have potential as quantitative and sensitive adjuncts to the American Spinal Injuries Association (ASIA) Impairment Scale (AIS) assessment of spinal cord injury (SCI).
SETTING: London, UK.
METHODS: EPT and SWM tests were carried out on 40 neurologically healthy individuals (20 male). One examiner carried out all the tests. Each individual was examined for EPT and SWM sensitivity at ASIA key points on four dermatomes (C4, T1, T6, L4) on both sides of the body. The tests were repeated after an interval of approximately 1 week. Intra-rater reliability was determined using intra-class correlation coefficients (ICC). Repeatability was determined using the method of Bland and Altman.
RESULTS: There were no significant differences in the mean values of EPT or SWM between assessments for any dermatome. Significant difference in mean values for both EPT and SWM were observed between some dermatomes. ICC ranged from 0.67 to 0.81 for the EPT and from 0.46 to 0.61 for the SWM. Higher ICC for the EPT compared with the SWM was again revealed when male and female subjects were assessed separately. Correlation between EPT and SWM was weak or (largely) absent.
CONCLUSION: EPT has better reliability than SWM in healthy subjects. However, as both tests have the potential to add sensitivity and resolution to the AIS assessment, a further comparison of their repeatability in SCI is warranted.

Entities:  

Mesh:

Year:  2012        PMID: 22945746     DOI: 10.1038/sc.2012.96

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  7 in total

Review 1.  Afferent input and sensory function after human spinal cord injury.

Authors:  Recep A Ozdemir; Monica A Perez
Journal:  J Neurophysiol       Date:  2017-07-12       Impact factor: 2.714

2.  Validation of a novel cone tool for pinprick sensation examination in patients with spinal cord injury.

Authors:  Genlin Liu; Jianjun Li; Hongjun Zhou; Ying Zheng; Chunxia Hao; Ying Zhang; Bo Wei; Yiji Wang; Haiqiong Kang; Xiaolei Lu
Journal:  Spinal Cord       Date:  2019-04-29       Impact factor: 2.772

3.  Subject-specific regional measures of water diffusion are associated with impairment in chronic spinal cord injury.

Authors:  Ann S Choe; Cristina L Sadowsky; Seth A Smith; Peter C M van Zijl; James J Pekar; Visar Belegu
Journal:  Neuroradiology       Date:  2017-06-08       Impact factor: 2.804

4.  Monitoring for myelopathic progression with multiparametric quantitative MRI.

Authors:  Allan R Martin; Benjamin De Leener; Julien Cohen-Adad; Sukhvinder Kalsi-Ryan; David W Cadotte; Jefferson R Wilson; Lindsay Tetreault; Aria Nouri; Adrian Crawley; David J Mikulis; Howard Ginsberg; Eric M Massicotte; Michael G Fehlings
Journal:  PLoS One       Date:  2018-04-17       Impact factor: 3.240

5.  Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current.

Authors:  Yushin Kim; Hang-Jun Cho; Hyung-Soon Park
Journal:  J Neuroeng Rehabil       Date:  2018-08-20       Impact factor: 4.262

6.  Obesity, but not overweight, is associated with plantar light touch sensation in children aged 8 to 16 years: A cross-sectional study.

Authors:  Toyin Ajisafe; Andrea Gilson; Theresa Garcia; Noe DeAnda
Journal:  Obes Sci Pract       Date:  2020-01-07

7.  Quantitative electrophysiological assessments as predictive markers of lower limb motor recovery after spinal cord injury: a pilot study with an adaptive trial design.

Authors:  Yin Nan Huang; El-Mehdi Meftah; Charlotte H Pion; Jean-Marc Mac-Thiong; Julien Cohen-Adad; Dorothy Barthélemy
Journal:  Spinal Cord Ser Cases       Date:  2022-02-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.